PHARMALEAD LIMITED

Company number 07991161 ·

Active

Net assets, total assets & total liabilities 2016 – 2025

  • Total assets
  • Net assets
  • Total liabilities
-£400k -£300k -£200k -£100k £0 £100k £200k £300k £400k 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Total assets 2016: £42,771 Total assets 2017: £25,263 Total assets 2018: £1,735 Total assets 2019: £1,735 Total assets 2020: £1,735 Total assets 2021: £1,735 Total assets 2023: £101,642 Total assets 2024: £242,999 Total assets 2025: £386,720 Total assets Net assets 2016: £30,458 Net assets 2017: £17,795 Net assets 2018: £139 Net assets 2019: £139 Net assets 2020: £139 Net assets 2021: £139 Net assets 2022: £10,181 Net assets 2023: £53,255 Net assets 2024: £56,289 Net assets 2025: £62,721 Net assets Total liabilities 2016: -£12,915 Total liabilities 2017: -£7,980 Total liabilities 2018: -£1,596 Total liabilities 2019: -£1,596 Total liabilities 2020: -£1,596 Total liabilities 2021: -£1,596 Total liabilities 2022: -£8,501 Total liabilities 2023: -£45,246 Total liabilities 2024: -£186,710 Total liabilities 2025: -£323,999 Total liabilities

Figures extracted from filed accounts. Hover a point for the exact value.

Employees 2024 – 2025

0 0 0 0 0 1 2024 2025 2024: 1 2025: 1

Average employees, from filed accounts. Hover a point for the exact figure.

Balance sheet by year 13 years

Latest accounts (2025-03-31): Audit exempt.

Year ending Total assets Total liabilities Net assets Cash Turnover Profit Employees
2025-03-31 £386,720 -£323,999 £62,721 1
2024-03-31 £242,999 -£186,710 £56,289 1
2023-03-31 £101,642 -£45,246 £53,255
2022-03-31 -£8,501 £10,181 £22,580
2021-03-31 £1,735 -£1,596 £139
2020-03-31 £1,735 -£1,596 £139
2019-03-31 £1,735 -£1,596 £139
2018-03-31 £1,735 -£1,596 £139
2017-03-31 £25,263 -£7,980 £17,795 £25,263
2016-03-31 £42,771 -£12,915 £30,458 £28,791
2015-03-31 £76,632 -£46,341 £30,291 £70,976
2014-03-31 £49,236 -£42,329 £6,907 £48,271
2013-03-31 £32,005 -£31,124 £881 £28,551

Profit and employee figures are captured from accounts filed from August 2026 onwards, where the accounts disclose them.